Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01185 (
vasopressin
)
23,126
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A conformation of the
neurohypophyseal
hormone oxytocin in solution is proposed. The structure possesses, in addition to the beta-turn comprised of the sequence -L-tyrosyl-L-isoleucyl-L-glutaminyl-L-asparaginyl- in the ring component of the hormonal molecule, a second beta-turn involving the C-terminal oxytocin sequence, -L-cysteinyl-L-prolyl-L-leucylglycinamide. The resulting oxytocin structure places the bulky side chains of the leucine and isoleucine residues, as well as the cyclic moiety of the
proline
residue, at corners of the two beta-turns. A critical role is played by the asparagine residue: its peptide N-H participates in the formation of the hydrogen-bonded cyclic structure of the beta-turn in the ring component of oxytocin and its peptide C=O can be hydrogen-bonded to the N-H of tyrosine, while its side chain C=O stabilizes the second beta-turn by forming a hydrogen bond with the N-H of the leucine residue, which is part of the end peptide of the second beta-turn. This conformational assignment of oxytocin is consistent with hydrogen-deuterium exchange studies, with plots of temperature dependence of peptide proton chemical shifts, and with the coupling constants for the NH-CH dihedral angles.
...
PMID:Proposed conformation of oxytocin in solution. 528 May 29
The hormonal regulation of gluconeogenesis and ureogenesis in isolated rat hepatocytes with 5 mM-
proline
as precursor was studied, with the following results. (1) The formation of glucose and urea in a 30 min interval were stimulated more by
vasopressin
than by glucagon, and the effects of the two hormones in combination were additive. (2) The rates of gluconeogenesis during the 30 min were constant under control, glucagon-stimulated and glucagon-plus-
vasopressin
-stimulated conditions. The stimulated rate in the presence of
vasopressin
diminished with time; glucagon in combination with
vasopressin
prevented this diminution, resulting in an additive effect. (3) Coincident with these changes in gluconeogenesis,
vasopressin
caused a decrease in cell oxoglutarate concentration, which, in contrast with the decrease caused by glucagon, was greater, but not sustained unless glucagon was also present. Changes in cell glutamate concentration similar to those observed for oxoglutarate occurred. (4) The data suggest that activation of oxoglutarate dehydrogenase (EC 1.2.4.2) by glucagon and
vasopressin
by different mechanisms may explain the relative effects of the hormones alone and in combination on gluconeogenesis from
proline
.
...
PMID:Distinct effects of glucagon and vasopressin on proline metabolism in isolated hepatocytes. The role of oxoglutarate dehydrogenase. 614 93
Eight analogues of oxytocin and
arginine-vasopressin
were synthesized, in which the
proline
residue in position 7 was replaced by either sarcosine or N-methylalanine; some of the pharmacological properties of these analogues were evaluated. In peptides containing a beta-mercaptopropionic acid residue in position 1, the additivity of the effects of deletion of the amino group in position 1 and of the above-noted replacements in position 7 on biological properties of these analogues was ascertained. All of the analogues were found to be potent in either antidiuretic or uterine activity and also selective in action. From the point of view of pharmacological properties, substitution of sarcosine in position 7 of oxytocin gave analogues with higher oxytocic and milk-ejecting activities than did the substitution of N-methylalanine. The opposite structure-activity relationship was observed with
arginine-vasopressin
, where the N-methylalanine-containing analogues were more potent than the sarcosine-containing analogues with respect to pressor activity and also, if not deaminated, with respect to antidiuretic activity.
...
PMID:Synthesis and some pharmacological properties of oxytocin and vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7. 618 21
Substituting sarcosine or N-methylalanine for
proline
in the inhibitory
vasopressin
analogs dPAVP and d(CH2)5AVP had the following effects: 1) milk ejection and antidiuretic activities were severely depressed, 2) pressor antagonism was maintained but weakened somewhat, and 3) antagonism in the uterus in vitro was maintained, but no consistent pattern was seen.
...
PMID:Influence of sarcosine or N-methylalanine in position 7 on the antagonistic properties of [1-deaminopenicillamine]- and [1-(beta-mercapto-beta, beta-cyclopentylmethylene-propionic acid)]-vasopressin. 619 18
Plasma membranes containing one class of non-cooperative binding sites for tritium-labelled [8-arginine]
vasopressin
were isolated from bovine kidney inner medulla and from rat liver. By using a weighted, non-linear least squares fit to logistic curves, the binding parameters of eight
vasopressin
agonists and antagonists were determined in competition experiments. Vasopressin analogues with sarcosine or N-methyl-L-alanine in position 7 instead of
proline
showed a high ratio of antidiuretic to vasopressor activity. These analogues retained a high binding affinity to the renal
vasopressin
receptor with apparent dissociation constants KD in the order
proline
less than sarcosine less than methylalanine . In contrast, the affinity to the hepatic
vasopressin
receptor, which shares characteristics with vasopressor receptors, was drastically reduced with KD values being in the order
proline
much less than N- methylalanine less than sarcosine. By combining the substitutions at position 7 with substitutions of cysteine in position 1 by either deaminopenicillamine or beta-mercapto-beta, beta-cyclopentamethylenepropionic acid, inhibitors of the oxytocoic and vasopressor responses were obtained. These additional substitutions at position 1 led to a drastic decrease in the binding affinity to the
vasopressin
receptor in bovine kidney. The intrinsic activity of these analogues to stimulate the renal
vasopressin
sensitive adenylate cyclase was strongly reduced or completely lost. In the rat liver system, however, these
vasopressin
antagonists showed a remarkably increased affinity to
vasopressin
receptors as compared to analogues substituted only at position 7. GTP reduced the binding affinity of all analogues to the hepatic receptor. The results show that these structural modifications which influence both the conformational properties of the
vasopressin
molecule and the biological activities of the hormone had strikingly different effects on the interactions of the resulting analogues with physiologically important receptors in the kidney and the liver. These studies may lead to the development of more specific
vasopressin
agonists and antagonists.
...
PMID:Interactions of vasopressin agonists and antagonists with membrane receptors. 632 26
14CO2 production from [l-14C]oleate, [l-14C]butyrate and [U-14C]
proline
by isolated rat hepatocytes was studied. In hepatocytes from fed rats, fatty acid and
proline
oxidation are stimulated in parallel by adrenaline, noradrenaline,
vasopressin
and angiotensin II. In contrast in hepatocytes from 24 h-starved rats these hormones stimulate
proline
oxidation whereas oleate and butyrate oxidation is hormone-insensitive. This suggests that 14CO2 production from [U-14C]
proline
and [l-14C]oleate is subject to independent endocrine control. In support of this in hepatocytes from fed rats, glucagon and dibutyryl cyclic AMP stimulate 14CO2 production from
proline
but inhibit 14CO2 production from [l-14C]oleate. The pathway of hepatic
proline
oxidation is discussed and it is suggested that 2-oxoglutarate dehydrogenase is one site of endocrine control of
proline
oxidation.
...
PMID:Can isolated spans of the tricarboxylic acid cycle operate independently? L-proline, oleate and butyrate metabolism in rat hepatocytes. 643 25
Oxalate was shown to enter isolated rat hepatocytes and to inhibit gluconeogenesis from lactate, pyruvate, and alanine, but not from glutamine,
proline
, propionate or dihydroxyacetone. Oxalate apparently acts by inhibiting pyruvate carboxylase (EC 6.4.1.1.). It is known to inhibit the isolated enzyme, and inhibition of gluconeogenesis was much greater in a bicarbonate-deficient medium where pyruvate carboxylase activity limits the overall rate of the pathway. A slight inhibition of gluconeogenesis from asparagine was observed, suggesting that oxalate may also inhibit gluconeogenesis at another site. Chelation of extracellular Ca2+ does not contribute to the inhibition of gluconeogenesis. Compared to oxalate, other Ca2+ chelators have little effect upon gluconeogenesis. Also, oxalate inhibits gluconeogenesis effectively both in low Ca2+ medium and in medium containing 2.6 mM Ca2+. Chelation of intracellular Ca2+ also appears to be of little importance, since oxalate does not block the glycogenolytic effects of epinephrine,
vasopressin
, and angiotensin which are thought to act via Ca2+ as the second messenger. The inhibition of gluconeogenesis could conceivably contribute to the toxic actions of oxalate and to the hypoglycemic action of dichloroacetate, a compound that is metabolized to oxalate. However, oxalate did not cause hypoglycemia in the suckling rat, a model in vivo system very dependent upon gluconeogenesis for maintenance of normal blood glucose levels. Thus, inhibition of gluconeogenesis is probably of little importance in oxalate toxicity and the hypoglycemic effects of dichloroacetate.
...
PMID:Studies on the inhibition of gluconeogenesis by oxalate. 677 9
A bovine brain thyrotropin-releasing-factor (thyroliberin) deamidase has been purified 1100-fold to apparent homogeneity. Molecular weight estimates by gel filtration and sodium dodecylsulfate gel electrophoresis indicate that the enzyme consists of a single polypeptide chain of molecular weight of about 62 000-65 000. The enzyme is inactivated by sulfhydryl blocking agents. Serine proteinase inhibitors, phenylmethanesulfonyl fluoride and benzamidine, have no effect. Besides thyroliberin, the enzyme hydrolyzes peptide bonds involving the carboxyl group of
proline
residues in luliberin, tuftsin, angiotensin II, melanotropin, and neurotensin. Oxytocin,
vasopressin
, and bradykinin are not cleaved; they are, however, strong competitive inhibitors of thyroliberin deamidation. The specificity studies indicate that the enzyme is a "post-
proline
cleaving enzyme" which hydrolyzes peptides of the general structure, Yaa-Pro-Xaa, in which Xaa = amino acid, peptide, or amide (not Pro), and Yaa = N-blocked basic amino acid or a peptide sequence in which the C-terminal residue (i.e. the residue prior to Pro) is a basic amino acid such as His, Lys, or Arg. The enzyme is compared to other post-
proline
cleaving enzymes.
...
PMID:Purification and properties of a bovine brain thyrotropin-releasing-factor deamidase. A post-proline cleaving enzyme of limited specificity. 679 65
The aim of the present study was to determine the magnitude and direction of the shift of body fluids during water immersion of humans to the neck. Five healthy male subjects were studied lying in air for 1.5 h, sitting in 34 degrees C water to the neck for 1 h, and again lying in air for 1.5 h in two sets of experiments. For the first set,
vasopressin
(0.75 IU, sc) was injected before immersion. Blood and urine samples were drawn every 30 min in air and every 20 min in water. Urinary sodium, potassium, and osmolal clearances were significantly increased during immersion. When the mean maximum change during immersion was calculated for five subjects hematocrit fell by 1.1 U, plasma concentrations of sodium by 3.9 meq/l, chloride by 3.5 meq/l, potassium by 0.2 meq/l, osmolality by 7.9 mosmol/kg H2O, and proteins by 0.25 g/100 ml, whereas total plasma CO2 content increased by 1.33 mmol/l, threonine by 11.6%,
proline
by 9.0%, methionine by 14.0%, and alanine by 29%. Plasma volume increased 6.1%, and red blood cell volume calculated from hematocrit and hemoglobin increased 3.5%. In the second set of immersion experiments, without
vasopressin
injection, interstitial fluid pressures were measured with a cotton wick in PE-50 tubing inserted subcutaneously. A mean interstitial fluid pressure of -0.5 cmH2O was observed when the subjects were lying in air. Interstitial fluid pressure had started to decrease by 20 min of immersion, with a maximum decrease during immersion averaging 2.10 cmH2O. We conclude that hyposmotic fluid is mobilized into the blood from interstitial and other extravascular spaces during immersion.
...
PMID:Osmoregulation and interstitial fluid pressure changes in humans during water immersion. 679 64
A post-proline cleaving enzyme [post-proline endopeptidase: EC 3.4.21.26] was purified from lamb brain by a series of column chromatographies on DEAE-Sephadex, hydroxyapatite and Sephadex G-150. The purified enzyme appeared homogeneous on disc gel and sodium dodecyl sulfate (SDS) gel electrophoreses. The enzyme was most active at pH 7.0 with carbobenzoxy-Gly-Pro-beta-naphthylamide (Z-Gly-Pro-2-NNap) as a substrate and catalyzed the hydrolysis of oxytocin,
vasopressin
, thyrotropin releasing hormone (TRH), substance P, luteinizing hormone releasing hormone (LH-RH), and angiotensin at the carboxyl side of their
proline
residues, except for the Pro2-Lys3 bond in substance P. From the results of subsite mapping using synthetic peptides, five subsites, S3 to S2', for substrate interaction with the enzyme were deduced to be present, and high stereospecificity was observed at S2, S1, and S1'. The isoelectric point of the enzyme was at pH 4.9, and the molecular weights estimated by gel filtration and SDS gel electrophoresis were 74,000 and 77,000, respectively. The enzyme was markedly inhibited by diisopropylphosphoro fluoridate (DFP), carbobenzoxy-Gly-Pro-chloromethyl ketone (Z-Gly-Pro-CH2Cl), p-chloromercuribenzoate (PCMB), Hg2+, and Cu2+ ions. These enzymatic and protein chemical properties of post-proline cleaving enzyme from lamb brain closely resemble those of the lamb kidney enzyme, except for the molecular weight. In the present work, however, we decided that the molecular weight of the enzyme from lamb kidney was also 74,000, which is different from that reported previously (J. Biol. Chem. 251, 7593 (1976) but is in accord with the value of post-proline cleaving enzyme from lamb brain.
...
PMID:Post-proline cleaving enzyme from lamb brain. 702 30
<< Previous
1
2
3
4
5
6
7
8
Next >>